Status:
WITHDRAWN
Ulcerative Colitis and Vitamin D Supplementation
Lead Sponsor:
University Hospital of North Norway
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Ulcerative colitis (UC) is an inflammatory disease involving the colonic mucosa, with bleedings and ulcerations. Consequences are destroyed mucosal barrier and increased permeability. Several cytokine...
Eligibility Criteria
Inclusion
- Men and women older than18 years old, diagnosed with UC (either debut or relapsed chronic UC), moderate or severe, where it is an indication to treat with infliximab.
Exclusion
- Primary hyperparathyroidism (PHPT)
- Sarcoidosis
- Renal failure (serum creatinine \> 125 mumol/L in men or \> 105 mumol/L in women)
- Those, who use solarium routinely are not included
- Pregnant or breastfeeding women, otherwise women of fertile age must be on approved birth control methods during the study
- Renal stones last 15 years
- Cancer of any origin, diagnosed during last 5 years
- Unstable angina pectoris
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01846026
Start Date
April 1 2013
End Date
December 1 2016
Last Update
June 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of North Norway
Tromsø, Norway, 9014